advertisement
Abstract #49080 Published in IGR 14-1
Glaucoma 2.0: Neuroprotection, Neuroregeneration, Neuroenhancement
Chang EE; Goldberg JLOphthalmology 2012; 119: 979-986
Glaucoma is a progressive neurodegenerative disease of retinal ganglion cells (RGCs) associated with characteristic axon degeneration in the optic nerve. Clinically, our only method of slowing glaucomatous loss of vision is to reduce intraocular pressure (IOP), but lowering IOP is only partially effective and does not address the underlying susceptibility of RGCs to degeneration. We review the recent steps forward in our understanding of the pathophysiology of glaucoma and discuss how this understanding has given us a next generation of therapeutic targets by which to maintain RGC survival, protect or rebuild RGC connections in the retina and brain, and enhance RGC function. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, USA.
Full articleClassification:
11.8 Neuroprotection (Part of: 11 Medical treatment)
